Stem cell therapy for type 1 diabetes mellitus

Nature Reviews Endocrinology

Volumn 6, Issue 3, 2010, Pages 139-148

  Aguayo Mazzucato, Cristina ^a   Bonner Weir, Susan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINAR CELL; AUTOIMMUNITY; CELL THERAPY; CLINICAL TRIAL; EMBRYONIC STEM CELL; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; LIVER CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; STROMA CELL; UMBILICAL CORD BLOOD;

CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 77649146795     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.274     Document Type: Review

References (145)

1. Atkinson, M. A. & Eisenbarth, G. S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358, 221-229 (2001).
2. Nathan, D. M. Finding new treatments for diabetes--how many, how fast, how good? N. Engl. J Med. 356, 437-440 (2007).
3. Nathan, D. M. Long-term complications of diabetes mellitus. N. Engl. J. Med. 328, 1676-1685 (1993).
4. Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238 (2000).
5. Ryan, E. A. et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50, 710-719 (2001).
6. Ricordi, C. & Strom, T. B. Clinical islet transplantation: advances and immunological challenges. Nat. Rev. Immunol. 4, 259-268 (2004).
7. Sibley, R. K., Sutherland, D. E., Goetz, F. & Michael, A. F. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 53, 132-144 (1985).
8. Alarcón, C., Serna, J., Pérez-Villamil, B. & de Pablo, F. Synthesis and differentially regulated processing of proinsulin in developing chick pancreas, liver and neuroretina. FEBS Lett. 436, 361-366 (1998).
9. Devaskar, S. U. et al. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J. Biol. Chem. 269, 8445-8454 (1994).
10. Hanahan, D. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr. Opin. Immunol. 10, 656-662 (1998).
11. Halban, P. A., Kahn, S. E., Lernmark, A. & Rhodes, C. J. Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 50, 2181-2191 (2001).
12. McLean, A. B. et al. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 25, 29-38 (2007).
13. Gadue, P., Huber, T. L., Paddison, P. J. & Keller, G. M. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl Acad. Sci. USA 103, 16806-16811 (2006).
14. Yasunaga, M. et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat. Biotechnol. 23, 1542-1550 (2005).
15. Tada, S. et al. Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 132, 4363-4374 (2005).
16. Kubo, A. et al. Development of definitive endoderm from embryonic stem cells in culture. Development 131, 1651-1662 (2004).
17. D'Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534-1541 (2005).
18. Asahina, K. et al. Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells. Genes Cells 9, 1297-1308 (2004).
19. Haegel, H. et al. Lack of beta-catenin affects mouse development at gastrulation. Development 121, 3529-3537 (1995).
20. Liu, P. et al. Requirement for Wnt3 in vertebrate axis formation. Nat. Genet. 22, 361-365 (1999).
21. Conlon, F. L. et al. A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 120, 1919-1928 (1994).
22. Brennan, J. et al. Nodal signalling in the epiblast patterns the early mouse embryo. Nature 411, 965-969 (2001).
23. Borowiak, M. et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 4, 348-358 (2009).
24. Lau, J., Kawahira, H. & Hebrok, M. Hedgehog signaling in pancreas development and disease. Cell Mol. Life Sci. 63, 642-652 (2006).
25. Stafford, D., Hornbruch, A., Mueller, P. R. & Prince, V. E. A conserved role for retinoid signaling in vertebrate pancreas development. Dev. Genes Evol. 214, 432-441 (2004).
26. Chen, S. et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 5, 258-265 (2009).
27. Kroon, E. et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452 (2008).
28. D'Amour, K. A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392-1401 (2006).
29. Jiang, J. et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25, 1940-1953 (2007).
30. Eshpeter, A. et al. In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells. Cell Prolif. 41, 843-858 (2008).
31. Shiraki, N. et al. Guided differentiation of embryonic stem cells into Pdx1-expressing regional-specific definitive endoderm. Stem Cells 26, 874-885 (2008).
32. Naujok, O. et al. Changes in gene expression and morphology of mouse embryonic stem cells on differentiation into insulin-producing cells in vitro and in vivo. Diabetes Metab. Res. Rev. 25, 464-476 (2009).
33. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
34. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945-949 (2008).
35. Huangfu, D. et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275 (2008).
36. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953 (2008).
37. Giorgetti, A. et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353-357 (2009).
38. Haase, A. et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434-441 (2009).
39. Tateishi, K. et al. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J. Biol. Chem. 283, 31601-31607 (2008).
40. Maehr, R. et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl Acad. Sci. USA 106, 15768-15773 (2009).
41. Chao, K. C., Chao, K. F., Fu, Y. S. & Liu, S. H. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One 3, e1451 (2008).
42. Denner, L. et al. Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif. 40, 367-380 (2007).
43. Hess, D. et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21, 763-770 (2003).
44. Oh, S. H. et al. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab. Invest. 84, 607-617 (2004).
45. Ianus, A., Holz, G. G., Theise, N. D. & Hussain, M. A. In vivo derivation of glucosecompetent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 111, 843-850 (2003).
46. Boumaza, I. et al. Autologous bone marrowderived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J. Autoimmun. 32, 33-42 (2009).
47. Lee, R. H. et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl Acad. Sci. USA 103, 17438-17443 (2006).
48. Sordi, V. et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106, 419-427 (2005).
49. Estrada, E. J. et al. Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus. Cell Transplant. 17, 1295-1304 (2008).
50. Lee, R. H. et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5, 54-63 (2009).
51. Wisniewski, H. G. & Vilcek, J. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine Growth Factor Rev. 15, 129-146 (2004).
52. Wisniewski, H. G. et al. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong antiinflammatory effect in vivo. J. Immunol. 156, 1609-1615 (1996).
53. Milner, C. M., Higman, V. A. & Day, A. J. TSG-6: a pluripotent inflammatory mediator? Biochem. Soc. Trans. 34, 446-450 (2006).
54. Getting, S. J. et al. The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha-inhibitor-independent manner. J. Biol. Chem. 277, 51068-51076 (2002).
55. Bonner-Weir, S. & Weir, G. C. New sources of pancreatic beta-cells. Nat. Biotechnol. 23, 857-861 (2005).
56. Suzuki, A., Nakauchi, H. & Taniguchi, H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 53, 2143-2152 (2004).
57. Seaberg, R. M. et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22, 1115-1124 (2004).
58. Ramiya, V. K. et al. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med. 6, 278-282 (2000).
59. Bonner-Weir, S. & Sharma, A. Pancreatic stem cells. J. Pathol. 197, 519-526 (2002).
60. Breault, D. T. et al. Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proc. Natl Acad. Sci. USA 105, 10420-10425 (2008).
61. Carlone, D. L., Bonner-Weir, S. & Breault, D. T. Identification of putative pancreatic progenitor/ stem cells using mTert-GFP mice. 5th ISSCR Annual Meeting 60 (2007).
62. Duncan, A. W., Dorrell, C. & Grompe, M. Stem cells and liver regeneration. Gastroenterology 137, 466-481 (2009).
63. Day, R. M. Epithelial stem cells and tissue engineered intestine. Curr. Stem Cell Res. Ther. 1, 113-120 (2006).
64. Sharma, A. et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48, 507-513 (1999).
65. Inada, A. et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc. Natl Acad. Sci. USA 105, 19915-19919 (2008).
66. Xu, X. et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132, 197-207 (2008).
67. Kikugawa, R. et al. Differentiation of COPASsorted non-endocrine pancreatic cells into insulin-positive cells in the mouse. Diabetologia 52, 645-652 (2009).
68. Bulotta, A. et al. Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1. J. Mol. Endocrinol. 29, 347-360 (2002).
69. Zhou, J., Wang, X., Pineyro, M. A. & Egan, J. M. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 48, 2358-2366 (1999).
70. Zhou, J., Pineyro, M. A., Wang, X., Doyle, M. E. & Egan, J. M. Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors. J. Cell. Physiol. 192, 304-314 (2002).
71. Mashima, H., Shibata, H., Mine, T. & Kojima, I. Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology 137, 3969-3976 (1996).
72. Mashima, H. et al. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J. Clin. Invest. 97, 1647-1654 (1996).
73. Hardikar, A. A., Marcus-Samuels, B., Geras-Raaka, E., Raaka, B. M. & Gershengorn, M. C. Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates. Proc. Natl Acad. Sci. USA 100, 7117-7122 (2003).
74. Noguchi, H., Bonner-Weir, S., Wei, F. Y., Matsushita, M. & Matsumoto, S. BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes 54, 2859-2866 (2005).
75. Noguchi, H., Kaneto, H., Weir, G. C. & Bonner-Weir, S. PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 52, 1732-1737 (2003).
76. Noguchi, H. et al. Induction of pancreatic stem/ progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell Transplant. 15, 929-938 (2006).
77. Bonner-Weir, S. et al. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl Acad. Sci. USA 97, 7999-8004 (2000).
78. Gao, R., Ustinov, J., Korsgren, O. & Otonkoski, T. In vitro neogenesis of human islets reflects the plasticity of differentiated human pancreatic cells. Diabetologia 48, 2296-2304 (2005).
79. Suarez-Pinzon, W. L., Lakey, J. R. & Rabinovitch, A. Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice. Cell Transplant. 17, 631-640 (2008).
80. Suarez-Pinzon, W. L., Lakey, J. R., Brand, S. J. & Rabinovitch, A. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass. J. Clin. Endocrinol. Metab. 90, 3401-3409 (2005).
81. Hao, E. et al. Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat. Med. 12, 310-316 (2006).
82. Yatoh, S. et al. Differentiation of affinity-purified human pancreatic duct cells to beta-cells. Diabetes 56, 1802-1809 (2007).
83. Gu, G., Dubauskaite, J. & Melton, D. A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129, 2447-2457 (2002).
84. Rooman, I. et al. Expression of the Notch signaling pathway and effect on exocrine cell proliferation in adult rat pancreas. Am. J. Pathol. 169, 1206-1214 (2006).
85. Hall, P. A. & Lemoine, N. R. Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J. Pathol. 166, 97-103 (1992).
86. Baeyens, L. et al. In vitro generation of insulinproducing beta cells from adult exocrine pancreatic cells. Diabetologia 48, 49-57 (2005).
87. Means, A. L. et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 132, 3767-3776 (2005).
88. Minami, K. et al. Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc. Natl Acad. Sci. USA 102, 15116-15121 (2005).
89. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627-632 (2008).
90. Zaret, K. S. & Grompe, M. Generation and regeneration of cells of the liver and pancreas. Science 322, 1490-1494 (2008).
91. Lemaigre, F. & Zaret, K. S. Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr. Opin. Genet. Dev. 14, 582-590 (2004).
92. Wilson, M. E., Scheel, D. & German, M. S. Gene expression cascades in pancreatic development. Mech. Dev. 120, 65-80 (2003).
93. Nagaya, M., Katsuta, H., Kaneto, H., Bonner-Weir, S. & Weir, G. C. Adult mouse intrahepatic biliary epithelial cells induced in vitro to become insulin-producing cells. J. Endocrinol. 201, 37-47 (2009).
94. Kojima, H. et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med. 9, 596-603 (2003).
95. Ferber, S. et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocininduced hyperglycemia. Nat. Med. 6, 568-572 (2000).
96. Ber, I. et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J. Biol. Chem. 278, 31950-31957 (2003).
97. Sapir, T. et al. Cell-replacement therapy for diabetes: Generating functional insulinproducing tissue from adult human liver cells. Proc. Natl Acad. Sci. USA 102, 7964-7969 (2005).
98. Zalzman, M., Anker-Kitai, L. & Efrat, S. Differentiation of human liver-derived, insulinproducing cells toward the beta-cell phenotype. Diabetes 54, 2568-2575 (2005).
99. Zalzman, M. et al. Reversal of hyperglycemia in mice by using human expandable insulinproducing cells differentiated from fetal liver progenitor cells. Proc. Natl Acad. Sci. USA 100, 7253-7258 (2003).
100. Keymeulen, B. et al. Insulin needs after CD3- antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352, 2598-2608 (2005). (Pubitemid 41007846)
101. Herold, K. C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692-1698 (2002).
102. Raz, I. et al. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 358, 1749-1753 (2001).
103. Saudek, F. et al. Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset. Rev. Diabet. Stud. 1, 80-88 (2004).
104. Trounson, A. New perspectives in human stem cell therapeutic research. BMC Med. 7, 29 (2009).
105. Haller, M. J. et al. Autologous umbilical cord blood infusion for type 1 diabetes. Exp. Hematol. 36, 710-715 (2008).
106. Voltarelli, J. C. et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297, 1568-1576 (2007).
107. Couri, C. E. et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301, 1573-1579 (2009).
108. Nathan, D. M. Progress in diabetes research-- what's next. JAMA 301, 1599-1601 (2009).
109. Viener, H. B. T. et al. Changes in regulatory T cells following autologous umbilical cord blood transfusion in children with type 1 diabetes. In Diabetes 67th American Diabetes Association Scientific Sessions, A82 (2007).
110. Haller, M. V. H. et al. Insulin requirements, HbA1c and stimulated C-peptide following autologous umbilical cord blood transfusion in children with type 1 diabetes. In Diabetes 67th American Diabetes Association Scientific Sessions A82 (2007).
111. Ende, N., Chen, R. & Reddi, A. S. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem. Biophys. Res. Commun. 325, 665-669 (2004).
112. Han, P., Hodge, G., Story, C. & Xu, X. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br. J. Haematol. 89, 733-740 (1995).
113. Fruchtman, S. Stem cell transplantation. Mt Sinai. J. Med. 70, 166-170 (2003).
114. Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144 (2009).
115. Belmonte, J. C., Ellis, J., Hochedlinger, K. & Yamanaka, S. Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nat. Rev. Genet. 10, 878-883 (2009).
116. Gangemi, A. et al. Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am. J. Transplant. 8, 1250-1261 (2008).
117. Shapiro, A. M. et al. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355, 1318-1330 (2006).
118. Lakey, J. R., Mirbolooki, M. & Shapiro, A. M. Current status of clinical islet cell transplantation. Methods Mol. Biol. 333, 47-104 (2006).
119. Tam, P. P., Kanai-Azuma, M. & Kanai, Y. Early endoderm development in vertebrates: lineage differentiation and morphogenetic function. Curr. Opin. Genet. Dev. 13, 393-400 (2003).
120. Xanthos, J. B., Kofron, M., Wylie, C. & Heasman, J. Maternal VegT is the initiator of a molecular network specifying endoderm in Xenopus laevis. Development 128, 167-180 (2001).
121. Kimelman, D. & Griffin, K. J. Vertebrate mesendoderm induction and patterning. Curr. Opin. Genet. Dev. 10, 350-356 (2000).
122. Zorn, A. M., Butler, K. & Gurdon, J. B. Anterior endomesoderm specification in Xenopus by Wnt/beta-catenin and TGF-beta signalling pathways. Dev. Biol. 209, 282-297 (1999).
123. Stainier, D. Y. A glimpse into the molecular entrails of endoderm formation. Genes Dev. 16, 893-907 (2002).
124. Xiao, L., Yuan, X. & Sharkis, S. J. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24, 1476-1486 (2006).
125. Heller, R. S. et al. Expression of Wnt, Frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expr. 11, 141-147 (2003).
126. Heller, R. S. et al. Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation. Dev. Dyn. 225, 260-270 (2002).
127. Deutsch, G., Jung, J., Zheng, M., Lóra, J. & Zaret, K. S. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 128, 871-881 (2001).
128. Kim, S. K. & Melton, D. A. Pancreas development is promoted by cyclopamine, a hedgehog signaling inhibitor. Proc. Natl Acad. Sci. USA 95, 13036-13041 (1998).
129. Norgaard, G. A., Jensen, J. N. & Jensen, J. FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. Dev. Biol. 264, 323-338 (2003).
130. Hart, A., Papadopoulou, S. & Edlund, H. Fgf10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells. Dev. Dyn. 228, 185-193 (2003).
131. Hald, J. et al. Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev. Biol. 260, 426-437 (2003).
132. Apelqvist, A. et al. Notch signalling controls pancreatic cell differentiation. Nature 400, 877-881 (1999).
133. Jensen, J. Gene regulatory factors in pancreatic development. Dev. Dyn. 229, 176-200 (2004).
134. Gradwohl, G., Dierich, A., LeMeur, M. & Guillemot, F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl Acad. Sci. USA 97, 1607-1611 (2000).
135. Heremans, Y. et al. Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J. Cell. Biol. 159, 303-312 (2002).
136. Offield, M. F. et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122, 983-995 (1996).
137. Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606-609 (1994).
138. Sharma, A. & Stein, R. Glucose-induced transcription of the insulin gene is mediated by factors required for beta-cell-type-specific expression. Mol. Cell. Biol. 14, 871-879 (1994). (Pubitemid 24036536)
139. Waeber, G., Thompson, N., Nicod, P. & Bonny, C. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol. Endocrinol. 10, 1327-1334 (1996).
140. Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K. & Edlund, H. Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 12, 1763-1768 (1998).
141. Naya, F. J., Stellrecht, C. M. & Tsai, M. J. Tissuespecific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev. 9, 1009-1019 (1995).
142. Sosa-Pineda, B., Chowdhury, K., Torres, M., Oliver, G. & Gruss, P. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 386, 399-402 (1997).
143. Blyszczuk, P. et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc. Natl Acad. Sci. USA 100, 998-1003 (2003).
144. Nishimura, W. et al. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev. Biol. 293, 526-539 (2006).
145. Aguayo-Mazzucato, C. K. A. et al. Reduced MafA Expression may contribute to the immaturity of neonatal beta cells. Diabetes 68th American Diabetes Association Scientific Sessions 1612 (2008).